Critics complain that state officials have given little guidance since ordering a recall of some $30 million in cannabis products. The delay, they say, could undermine confidence in the legal market.
Earlier this week, regulators in New York announced the largest recall of cannabis products in the state’s short history of legalization.
Three days have passed. Yet there has been no official notice about how the recall affects more than $30 million worth of cannabis products that regulators said were slipped into dispensaries by companies without the proper licensing. The backdoor channel was made possible by illegal arrangements made with Omnium Health, one of the state’s largest makers of cannabis goods.
State regulators do not have a deadline to start the recall. But some experts in the cannabis industry say that officials are taking too long to take the action, which has stirred confusion in the industry, risked the safety of consumers and could renew doubts about legalization all together.
Read the full article at The New York Times
